CEO's On the Move

Advanced Oncotherapy Plc Appoints Nicolas Serandour as Chief Executive Officer
Advanced Oncotherapy Plc (AVO:LN:London Stock Exchange) Advanced Oncotherapy Plc announced that Nicolas Serandour, Chief Operating Officer and Chief Financial Officer, will become Chief Executive Officer with immediate effect. Michael Sinclair, currently Chief Executive Officer and Executive Chairman, will retain his role as Executive Chairman.

Upcoming Board Meetings

Eni SpA
(ENI:IM:Milan Stock Exchange)
October 27, 2016
Eni SpA, Board Meeting, Oct 27, 2016. Agenda: To approve third quarter 2016 results.
Announced 01/4/16
Eni SpA Key Board Members
Emma Marcegaglia
Chairman of the Board
Claudio Descalzi
Chief Executive Officer, General Manager and Director
Umberto Vergine
Chief Midstream Gas & Power Officer and Non-Independent Executive Director of Saipem ...

Executive Changes

SPCG Public Company Limited Announces Executive Changes
SPCG Public Company Limited announced that Ms. Suwaporn Sirikoon, Deputy Chief Executive Officer of company had a work period due on October 21, 2016. Therefore, the Company has appointed Mr. Jirakom Patumanon, Director as the new Deputy Chief Executive Officer effective from October 22, 2016 onward.
MD Medical Group Investments plc Announces Executive Changes, Effective October 28, 2016
MD Medical Group Investments Plc announced a change in its management team. The company announced that Vitalii Ustimenko is to step down as Deputy CEO for Economics and Finance and Andrey Khoperskiy, currently MDMG's Director of Finance, will take over the position of Deputy CEO for Economics and Finance. Vitalii Ustimenko will remain on the board of directors of MDMG. The changes will take effect as of October 28, 2016. Andrey Khoperskiy joined the Group as Head of Finance controlling and Treasury in 2013, he was appointed to a position Director for Finance of the Group in 2016. Previously, Andrey worked for Rusagro Group and Sukhoi. Aviation Holding Company as a Finance manager and earlier he was an Auditor in BDO Russia.
Vela Minerals Ltd. Announces Resignation of Brady Fletcher as Director
Vela Minerals Ltd. announced the resignation of Brady Fletcher from the Board of Directors of the Company. Mr. Fletcher has accepted an appointment of Managing Director of the TSX Venture Exchange (TSXV). As a requirement of this appointment, Mr. Fletcher has agreed to not participate as a board member of any company.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Top Compensated Executives at AVO:LN

Name/TitleAnnual Compensation
Michael Sinclair435.0K GBP
Executive Chairman, Chief Executive Officer, Member of Remuneration Committee and Member of Audit Committee
Nicolas Serandour316.5K GBP
Chief Financial Officer, Chief Operating Officer and Executive Director
Sanjeev Pandya411.8K GBP
Executive Vice President for Global Business Development and Executive Director
Compensation as of Fiscal Year 2015. All Compensation is in USD.

Average Compensation in the Healthcare Providers and Services Industry

Healthcare Providers and Services
Healthcare Distributors
Healthcare Services
Healthcare Facilities
Managed Healthcare
Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at